Join
Live feed
·
INSIDERFilingvia Quantisnow
BridgeBio Pharma Inc. logo

Director Valantine Hannah sold $207,327 worth of shares (4,707 units at $44.05), decreasing direct ownership by 24% to 7,465 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
BBIO· BridgeBio Pharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBIO (BridgeBio Pharma Inc.) and more on Quantisnow.